EpiDestiny

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, EpiDestiny sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).

4 total trials 1 currently recruiting 3 completed early-phase tilt upper quartile by trial count

EpiDestiny: 4 sponsored US clinical trials, 1 recruiting.

EpiDestiny sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 1 trials.

Upper-quartile sponsor footprint

EpiDestiny sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

4 total, page 1 of 1

RECRUITING Phase 1

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

NCT04055818
COMPLETED Phase 1

To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males

NCT05816356
COMPLETED Phase 1

Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult Subjects

NCT04086238
COMPLETED Phase 1

Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy Subjects

NCT03828084

Phase Distribution

PhaseTrial count
Phase 1 4

Therapeutic Areas

Healthy 1
Sickle Cell Disease 1

What is open in the EpiDestiny pipeline

1 recruiting of 4 indexed (25% open); 3 completed (75%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Healthy (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.